Hereditary non-polyposis colorectal cancer (HNPCC) is caused by a germline mutation in one of the DNA mismatch repair (MMR) genes. Tumors that develop in a person with HNPCC have a very large number of microsatellite instability (MSI). Approximately 15% of all colorectal cancers have MSI and in most instances this is due to acquired genetic defects in the DNA MMR system, rather than a germline mutation. Therefore, in addition to being perhaps the most common form of an inherited predisposition to cancer, HNPCC has been a model for the understanding of genomic instability in sporadic tumors. We are interested in HNPCC for two reasons. First, our laboratory has established in vitro models in which to study the biology of normal DNA MMR activity and how mutations in the MMR genes affect the cell cycle. Secondly, as a laboratory dedicated to transnational investigation, we are interested in the clinical side of HNPCC. A central theme of this application is that we can find the germline basis of HNPCC in only about half of such families. We have hypothesized that there are additional genes participating in the DNA MMR system that may be responsible for HNPCC. We have data suggesting that there is another DNA MMR gene on chromosome 3. We have hypothesized that different types of mutations in the known HNPCC genes alter the DNA MMR system in different ways which may be responsible for the various phenotypes seen in this disease. We are part of the UC Irvine-UC San Diego collaborative Cancer Genetics Network, which will provide us with a large data base of familial colorectal tumors. We will use this data base to obtain tumor tissue and blood from patients with familial forms of colorectal cancer. We will first determine whether all colorectal cancers can be divided into one of the two known mechanisms of genomic instability. We will look for new germline mutations that might be responsible for HNPCC. Finally, we will microdissect tumors with MSI and determine which genes are mutated in the tumor progression sequence. We have hypothesized that the traditional """"""""gatekeepers"""""""" for adenoma formation and conversion to carcinoma may not be the same as those that occur in tumors without MSI. In summary, we propose to study the basic biology of the DNA MMR system in vitro, and use this information to develop insight into the clinical behavior and the diagnostic strategies for HNPCC, predisposition to cancer, HNPCC, has been a model for understanding genomic instability in sporadic tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA072851-05
Application #
6164230
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Lively, Tracy (LUGO)
Project Start
1996-05-10
Project End
2004-02-29
Budget Start
2000-03-20
Budget End
2001-02-28
Support Year
5
Fiscal Year
2000
Total Cost
$333,212
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Wang, Wei; Kandimalla, Raju; Huang, Hao et al. (2018) Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities. Semin Cancer Biol :
Ravindranathan, Preethi; Pasham, Divya; Balaji, Uthra et al. (2018) A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer. Sci Rep 8:13869
Ozawa, Tsuyoshi; Kandimalla, Raju; Gao, Feng et al. (2018) A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes. Gastroenterology 154:844-848.e7
Boland, Patrick M; Yurgelun, Matthew B; Boland, C Richard (2018) Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J Clin 68:217-231
Kandimalla, Raju; Gao, Feng; Matsuyama, Takatoshi et al. (2018) Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer. Clin Cancer Res 24:3867-3877
Ruiz-Bañobre, Juan; Goel, Ajay (2018) DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers. Gastroenterology :
Perea, José; García, Juan L; Corchete, Luis et al. (2018) Redefining synchronous colorectal cancers based on tumor clonality. Int J Cancer :
Toden, Shusuke; Ravindranathan, Preethi; Gu, Jinghua et al. (2018) Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer. Sci Rep 8:3335
Weng, Wenhao; Liu, Na; Toiyama, Yuji et al. (2018) Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer. Mol Cancer 17:16
Takehara, Yuko; Nagasaka, Takeshi; Nyuya, Akihiro et al. (2018) Accuracy of four mononucleotide-repeat markers for the identification of DNA mismatch-repair deficiency in solid tumors. J Transl Med 16:5

Showing the most recent 10 out of 178 publications